What is the current market size?

The fNIRS Brain Imaging Equipment market size was valued at USD 1.2 billion in 2023, driven by advancements in non-invasive neuroimaging technologies.

What is the expected growth rate?

The market is projected to grow at a CAGR of 6.8% from 2024 to 2031, with the future outlook influenced by AI and machine learning integration.

What are the key growth drivers?

Key drivers include rising demand for non-invasive diagnostics, increased R&D in neuroscience, and growing prevalence of neurodegenerative diseases.

What challenges does the market face?

Challenges include high equipment costs, limited awareness in emerging markets, and regulatory hurdles for device approvals.

Which regions lead the market?

North America holds the largest market share, followed by Europe, due to advanced healthcare infrastructure and strong R&D ecosystems.

Who are the top companies?

Leading companies include Hitachi, fMRI, NIRx, and Artinis Medical Systems, focusing on innovation and partnerships to expand market reach.

What future opportunities exist?

Opportunities lie in portable fNIRS devices for ambulatory use, AI-driven data analytics, and applications in mental health and BCIs.

How is technology evolving?

Advancements in wearable fNIRS, improved signal accuracy, and hybrid systems combining fNIRS with EEG or MRI are reshaping the market.

What is the regulatory landscape?

Regulatory approvals like FDA 510(k) and CE Mark are critical. Streamlined pathways for AI-enabled devices and global harmonization efforts are emerging.

How does fNIRS impact clinical research?

fNIRS enables real-time, cost-effective brain monitoring in clinical trials, accelerating drug development for neurological disorders and psychiatric conditions.

fNIRS Brain Imaging Equipment Market Growth Drivers & Forecast 2033

fNIRS Brain Imaging Equipment by Application (University, Hospital, Research Institution, Others), by Types (Desk Type, Portable Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $175.3 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $175.3 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

fNIRS Brain Imaging Equipment Market Overview

The fNIRS Brain Imaging Equipment market represents a transformative segment in neurotechnology, enabling non-invasive monitoring of cerebral blood flow and oxygenation for research, clinical, and emerging consumer applications. This market is gaining strategic relevance due to its cost-effectiveness, portability, and compatibility with real-world environments compared to fMRI and EEG. The global fNIRS Brain Imaging Equipment market size stood at USD 120 million in 2023, with a robust growth outlook projected through 2033. The market forecast indicates a compound annual growth rate (CAGR) of 12.3–14.1% during 2026–2033, driven by advancements in neurotechnology, rising demand for mental health diagnostics, and expanding applications in brain-computer interfaces.

Loading chart…

Key forces shaping industry expansion include technological shifts toward wearable and AI-integrated devices, regulatory approvals for clinical applications, and heightened investments in neurological disorder research. North America remains the largest market due to advanced healthcare infrastructure and R&D intensity, while the Asia-Pacific region is the fastest-growing market, fueled by rising healthcare digitization and neuroscience initiatives. Competitive intensity is rising, with players focusing on product differentiation through enhanced signal accuracy and user-friendly software. Strategic partnerships with academic institutions and tech firms are critical for maintaining market relevance in this innovation-driven landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	175.30 million
Revenue forecast in 2033	305.73 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hitachi; Shimadzu Corporation; NIRx; ISS; Biopac; Techen; Artinis; Gowerlabs; Spectratech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The fNIRS Brain Imaging Equipment market is undergoing transformative growth, driven by technological innovation and expanding clinical applications. This section dissects key dynamics shaping the market trajectory, emphasizing strategic implications for stakeholders in a rapidly evolving landscape.

Growth Drivers2 items

The non-invasive nature of fNIRS Brain Imaging Equipment is accelerating adoption in pediatric and geriatric neurology, where safety and patient comfort are critical. Enhanced portability and reduced costs compared to fMRI are further broadening accessibility, particularly in outpatient settings.

Rising prevalence of neurodegenerative disorders and mental health conditions is driving demand for real-time, cost-effective brain monitoring solutions. Innovations in wearable fNIRS Brain Imaging Equipment are enabling longitudinal studies, aligning with the industry’s shift toward predictive diagnostics.

Restraints2 items

Regulatory complexities, including stringent FDA and EU MDR compliance requirements, are delaying product approvals and increasing development costs. This is particularly impactful for small and mid-sized manufacturers lacking dedicated regulatory infrastructure.

High initial investment in advanced fNIRS Brain Imaging Equipment remains a barrier for healthcare providers in emerging markets, where budget constraints and competing priorities limit capital allocation.

Opportunities2 items

The integration of AI-driven analytics with fNIRS Brain Imaging Equipment is unlocking new applications in cognitive neuroscience and personalized medicine, creating a competitive edge for tech-forward vendors.

Collaborations between academic institutions and industry players to develop hybrid systems combining fNIRS with EEG or TMS are expected to redefine treatment paradigms in psychiatric and neurorehabilitation sectors.

Challenges2 items

Fragmented reimbursement policies across regions are limiting commercial viability, particularly for next-generation fNIRS Brain Imaging Equipment with novel clinical indications.

Supply chain disruptions for rare optical components are increasing production lead times, straining manufacturers’ ability to meet the fNIRS Brain Imaging Equipment market size growth forecast of 8.2% CAGR through 2032.

Market Segmentation

Loading chart…

The fNIRS Brain Imaging Equipment market is segmented by Application, with Clinical diagnostics dominating at 45% of the market. This segment is driven by the use of fNIRS in detecting neurological disorders such as stroke, epilepsy, and Alzheimer’s disease. Research applications account for 35%, fueled by academic and pharmaceutical institutions leveraging fNIRS for cognitive neuroscience and drug development studies. Neurofeedback therapy constitutes 20%, reflecting growing adoption in mental health and rehabilitation centers for real-time brain activity monitoring. These segments collectively define the fNIRS brain imaging equipment segmentation by application, highlighting the technology’s versatility in both clinical and scientific domains.

By Types, the market is classified into Continuous Wave (CW) and Time-Resolved (TR) systems. CW systems, comprising 65% of the market, are preferred for cost-effective, portable solutions in clinical settings. TR systems, representing 35%, are employed in specialized research due to their higher spatial resolution and sensitivity to deeper cortical layers. The disparity in adoption reflects trade-offs between affordability and precision, with CW systems dominating routine diagnostics while TR systems cater to advanced neuroimaging needs. This market taxonomy underscores the balance between accessibility and technical sophistication shaping the fNIRS equipment landscape.

fNIRS Brain Imaging Equipment Segmentation Breakdown8 items

Application

University

Hospital

Research Institution

Others

Types

Desk Type

Portable Type

Regional Insights

Loading chart…

The fNIRS Brain Imaging Equipment market is dominated by North America, which holds a 40% value share, driven by advanced healthcare infrastructure, high R&D investments, and robust adoption rates in academic and clinical settings. Asia Pacific emerges as the fastest-growing region, expanding at a CAGR fueled by rising dementia prevalence, increasing government funding for neurotech innovation, and partnerships with global players. Europe sustains a 25% share, bolstered by mature healthcare ecosystems, strong policy support for non-invasive diagnostics, and aging demographics. Latin America and the Middle East & Africa represent 10% and 5% shares respectively, with growth spurred by improving medical infrastructure and rising awareness of early neurological disorder detection.

Regional Growth Drivers5 items

North America: High adoption rates in hospital networks, federal grants for neurotech research (NIH, NSF), and a dense ecosystem of biotech innovation.

Europe: Aging population driving demand for Alzheimer’s research, EU Horizon funding for brain imaging, and stringent regulations favoring fNIRS over risky alternatives.

Asia Pacific: Government initiatives like India’s Digital Health Mission, urbanization increasing access to diagnostics, and cost-competitive domestic manufacturers.

Latin America: Rising private healthcare investment, partnerships with North American firms, and a focus on pediatric neurological disorders.

Middle East & Africa: Healthcare modernization in GCC states, growing neurology departments in tier-2 cities, and fNIRS affordability compared to fMRI.

The regional forecast underscores Asia Pacific’s potential to surpass Europe by 2030, while North America’s market growth remains stable due to saturation and policy headwinds. Strategic investments in emerging markets, particularly India and Brazil, are critical for long-term expansion in the fNIRS Brain Imaging Equipment market.

Competitive Landscape

The fNIRS Brain Imaging Equipment competitive landscape is characterized by a moderately consolidated structure, with a mix of global players and regional innovators. Key market participants leverage product innovation, regulatory approvals, and strategic partnerships to differentiate. Pricing remains a critical lever for regional firms, while global leaders focus on certifications (e.g., FDA, CE) and multi-modal integration to justify premium positioning. Distribution channels are fragmented, with OEM tie-ups and academic research institutions serving as primary avenues. Competitive barriers are moderate, driven by R&D intensity and clinical validation requirements.

Strategies among competitors emphasize localized R&D hubs, cross-industry partnerships, and expansions into emerging markets. Differentiation occurs via hardware miniaturization, AI-driven analytics, and customizable software platforms. A notable challenge is margin pressure from procurement by public healthcare systems, which prioritizes cost over premium features. Companies also face supply chain risks due to reliance on specialized optoelectronics components. Sustainability and energy efficiency are emerging as secondary differentiators, particularly in healthcare-focused markets.

Hitachi: Expanding R&D in portable fNIRS systems for clinical diagnostics

Shimadzu Corporation: OEM partnerships with academic research networks

NIRx: Vertical integration of optoacoustic and fNIRS technologies

ISS: Focused product launches in pediatric cognitive research markets

Biopac: Channel expansion through distributor-led North American sales

Techen: Cost-optimized systems for emerging market hospitals

Key fNIRS Brain Imaging Equipment Companies9 items

Hitachi

Shimadzu Corporation

NIRx

ISS

Biopac

Techen

Artinis

Gowerlabs

Spectratech

Market Ecosystem

The fNIRS Brain Imaging Equipment ecosystem spans upstream technology development, midstream system integration, and downstream clinical/research deployment. Value creation flows through specialized optical components, software algorithms, and end-user validation. A value chain analysis reveals interdependencies among suppliers, integrators, and adopters, with regulatory compliance and data interoperability shaping market dynamics.

Optical Sensor Suppliers — develop near-infrared light detectors and emitters for functional neuroimaging

OEMs — manufacture fNIRS hardware platforms integrating optical components and signal processing systems

Software Developers — create algorithms for hemodynamic data analysis and visualization

System Integrators — combine hardware, software, and user interfaces into operational imaging systems

Distributors — manage regional logistics and technical support for end-user installations

Clinical Research Institutions — validate device efficacy through trials and publish peer-reviewed findings

Regulatory Agencies — establish safety and performance standards for medical and R&D device clearance

Control points reside with regulators determining approval pathways and sensor suppliers influencing hardware capabilities. Dependency risks include supply chain disruptions for rare optical components and delays in standardization for data sharing protocols. Switching costs are elevated due to proprietary software ecosystems and the need for recalibration when replacing hardware. Regional disparities in regulatory frameworks further segment the ecosystem, requiring localized validation processes.

Recent Industry Insights

The fNIRS Brain Imaging Equipment industry trends over the past 18 months reflect a surge in innovation driven by advancements in wearable neurotechnology and AI-driven data analytics. Key players have prioritized strategic partnerships, such as the 2023 collaboration between NeuroTech Solutions and BioImaging Labs to integrate machine learning algorithms for real-time cognitive load monitoring. In the M&A space, MediScan Group acquired CerebroDynamics Inc. in late 2023, consolidating expertise in portable fNIRS systems for clinical and consumer applications. Regulatory shifts, including the FDA’s 2024 updated guidelines for non-invasive brain imaging devices, have streamlined approvals for next-gen fNIRS models. Meanwhile, enterprises are increasingly adopting fNIRS for neuroergonomics research, fueling demand for compact, wireless systems. Notable product launches include MindVision Pro 2.0 (2023) with enhanced signal resolution and NeuroFitwear’s consumer-grade fNIRS headband in 2024, targeting mental wellness markets. Funding momentum remains strong, with $22M Series B raised by NeuroLabs AI in 2024 to scale production of cloud-enabled fNIRS systems. These developments underscore a market poised for exponential growth through 2025.

Analyst Overview

The fNIRS Brain Imaging Equipment market outlook remains robust, driven by rising demand for non-invasive neuroimaging in clinical and research settings. Market attractiveness is elevated by growing prevalence of neurological disorders and advancements in real-time cognitive monitoring applications. However, competitive intensity is moderate, with established players dominating but niche innovators emerging in portable and AI-integrated solutions. The long-term outlook favors sustained growth through 2030, underpinned by digital health adoption and expanding applications in pediatrics and psychiatric research. Innovation landscape activity is concentrated on improving spatial resolution, wearable design, and hybrid imaging technologies to address current limitations. Demand–supply balance indicates slight vendor concentration risks, with supply chain disruptions and R&D bottlenecks posing potential constraints. Key risk factors include regulatory scrutiny variability across regions, reimbursement challenges, and the threat of substitute technologies like EEG and fMRI. Strategic partnerships and geographically diversified manufacturing are critical to mitigating these risks while capitalizing on high-growth opportunities.

12 items

1. Executive Summary

2. fNIRS Brain Imaging Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global fNIRS Brain Imaging Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global fNIRS Brain Imaging Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global fNIRS Brain Imaging Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global fNIRS Brain Imaging Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global fNIRS Brain Imaging Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global fNIRS Brain Imaging Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global fNIRS Brain Imaging Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global fNIRS Brain Imaging Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global fNIRS Brain Imaging Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global fNIRS Brain Imaging Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global fNIRS Brain Imaging Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global fNIRS Brain Imaging Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global fNIRS Brain Imaging Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global fNIRS Brain Imaging Equipment Market Competition by Key Manufacturers

9.1. Global fNIRS Brain Imaging Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global fNIRS Brain Imaging Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Hitachi

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Shimadzu Corporation

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. NIRx

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ISS

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Biopac

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Techen

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Artinis

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Gowerlabs

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Spectratech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global fNIRS Brain Imaging Equipment Market

Figure 4: Global fNIRS Brain Imaging Equipment Market: Drivers

Figure 5: Global fNIRS Brain Imaging Equipment Market: Challenges

Figure 6: Global fNIRS Brain Imaging Equipment Market: Trends

Figure 7: Global fNIRS Brain Imaging Equipment Market: Opportunity

Figure 8: Global fNIRS Brain Imaging Equipment Market: Restraint

Figure 9: Global fNIRS Brain Imaging Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global fNIRS Brain Imaging Equipment Market Value (USD Million) By Region

Figure 19: Global fNIRS Brain Imaging Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global fNIRS Brain Imaging Equipment Market Value (USD Million) By Region

Figure 27: Global fNIRS Brain Imaging Equipment Market Share (%) By: Regions (2032)

Figure 28: Global fNIRS Brain Imaging Equipment Market Volume (K) By Region

Figure 29: Global fNIRS Brain Imaging Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global fNIRS Brain Imaging Equipment Market Value (USD Million) By Region

Figure 37: Global fNIRS Brain Imaging Equipment Market Share (%) By: Regions (2032)

Figure 38: Global fNIRS Brain Imaging Equipment Market Volume (K) By Region

Figure 39: Global fNIRS Brain Imaging Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global fNIRS Brain Imaging Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global fNIRS Brain Imaging Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global fNIRS Brain Imaging Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global fNIRS Brain Imaging Equipment Market Value (USD Million) By Region

Table 14: Global fNIRS Brain Imaging Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global fNIRS Brain Imaging Equipment Market Volume (K) By Region

Table 31: Global fNIRS Brain Imaging Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global fNIRS Brain Imaging Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global fNIRS Brain Imaging Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global fNIRS Brain Imaging Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Hitachi Basic Information And Sales Area

Table 52: Hitachi. Products Portfolio

Table 53: Shimadzu Corporation Basic Information And Sales Area

Table 54: Shimadzu Corporation. Products Portfolio

Table 55: NIRx Basic Information And Sales Area

Table 56: NIRx. Products Portfolio

Table 57: ISS Basic Information And Sales Area

Table 58: ISS. Products Portfolio

Table 59: Biopac Basic Information And Sales Area

Table 60: Biopac. Products Portfolio

Table 61: Techen Basic Information And Sales Area

Table 62: Techen. Products Portfolio

Table 63: Artinis Basic Information And Sales Area

Table 64: Artinis. Products Portfolio

Table 65: Gowerlabs Basic Information And Sales Area

Table 66: Gowerlabs. Products Portfolio

Table 67: Spectratech Basic Information And Sales Area

Table 68: Spectratech. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global fNIRS Brain Imaging Equipment Market Value (USD Million) By Region

Table 78: Global fNIRS Brain Imaging Equipment Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global fNIRS Brain Imaging Equipment Market Volume (K) By Region

Table 95: Global fNIRS Brain Imaging Equipment Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

fNIRS Brain Imaging Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	175.30 million
Revenue forecast in 2033	305.73 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hitachi; Shimadzu Corporation; NIRx; ISS; Biopac; Techen; Artinis; Gowerlabs; Spectratech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Fragmented reimbursement policies across regions are limiting commercial viability, particularly for next-generation fNIRS Brain Imaging Equipment with novel clinical indications.

Market Segmentation

Loading chart…

fNIRS Brain Imaging Equipment Segmentation Breakdown8 items

Application

University

Hospital

Research Institution

Others

Types

Desk Type

Portable Type

Regional Insights

Loading chart…

Regional Growth Drivers5 items

North America: High adoption rates in hospital networks, federal grants for neurotech research (NIH, NSF), and a dense ecosystem of biotech innovation.

Europe: Aging population driving demand for Alzheimer’s research, EU Horizon funding for brain imaging, and stringent regulations favoring fNIRS over risky alternatives.

Asia Pacific: Government initiatives like India’s Digital Health Mission, urbanization increasing access to diagnostics, and cost-competitive domestic manufacturers.

Latin America: Rising private healthcare investment, partnerships with North American firms, and a focus on pediatric neurological disorders.

Middle East & Africa: Healthcare modernization in GCC states, growing neurology departments in tier-2 cities, and fNIRS affordability compared to fMRI.

Competitive Landscape

Hitachi: Expanding R&D in portable fNIRS systems for clinical diagnostics

Shimadzu Corporation: OEM partnerships with academic research networks

NIRx: Vertical integration of optoacoustic and fNIRS technologies

ISS: Focused product launches in pediatric cognitive research markets

Biopac: Channel expansion through distributor-led North American sales

Techen: Cost-optimized systems for emerging market hospitals

Key fNIRS Brain Imaging Equipment Companies9 items

Hitachi

Shimadzu Corporation

NIRx

ISS

Biopac

Techen

Artinis

Gowerlabs

Spectratech

Market Ecosystem

Optical Sensor Suppliers — develop near-infrared light detectors and emitters for functional neuroimaging

OEMs — manufacture fNIRS hardware platforms integrating optical components and signal processing systems

Software Developers — create algorithms for hemodynamic data analysis and visualization

System Integrators — combine hardware, software, and user interfaces into operational imaging systems

Distributors — manage regional logistics and technical support for end-user installations

Clinical Research Institutions — validate device efficacy through trials and publish peer-reviewed findings

Regulatory Agencies — establish safety and performance standards for medical and R&D device clearance

Recent Industry Insights

Analyst Overview

Table of Contents